Treatment of irritable bowel syndrome using probiotic composition
AssigneeCobb and Company, LLP
InventorsMark L. Cobb, Alyson Cobb
Life of this patent
Estimating the term…
Abstract
A method of treating irritable bowel syndrome using a probiotic composition including the bacilli (1) Bacillus subtilis, (2) Bacillus coagulans, and (3) Enterococcus faecium. The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the invention may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders.
Claims14
A method of treating an individual suffering from irritable bowel syndrome, comprising administering to said individual a probiotic composition comprising (i) Bacillus subtilis, (ii) Bacillus coagulans and (iii) Enterococcus faecium, wherein the composition comprises:
- (i) Bacillus subtilis, in an amount of 25 million to 1.5 billion colony forming units (CFUs);
- (ii) Bacillus coagulans in an amount of 50 million to 2 billion colony forming units (CFUs);
- and
- (iii) Enterococcus faecium in an amount of 25 million to 1.5 billion colony forming units (CFUs).
Dependencies are inferred from the claim text.